What is the main business of Altergomed?

The main business activity of Altergomed focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 31, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Włodarzewska 67C, 02-384 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

How much revenue was generated?

The company reported a revenue of $53,277 in 2023.

No, in 2023 the company was not profitable, reporting a net loss of $9,565.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $27,203 in 2023, representing 43% of all operating expenses.

Altergomedsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2015-03-31

Share capital

5,000.00 PLN

Registered address

ul. Włodarzewska 67C/27, 02-384 Warszawa, Poland

Electronic delivery address

AE:PL-53641-33471-BFWWR-23

Financials

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 5 of 6 financial statements not filed.

2024not filed
202309/07/2024
2022not filed
2021not filed
2020not filed
2019not filed

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue

This companyUSD 53.28kMedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD -9.56kMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 62.84kMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 3.76kMedianUSD 608.93kAverageUSD 11.85m

Industry

Authorized Representatives

Andrzej Jan Omieciński – President of the Management Board

Manner of representation

Each member of the management board independently.

Ownership

Owner	Shares	Share value	Stake
Andrzej Jan Omiecińskiage 79	60	$810.37	60%
Urszula Witkowska Omiecińskaage 63	40	$540.25	40%

Andrzej Jan Omieciński and Urszula Witkowska Omiecińska hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2015-04-12.

Bank Pekao SA
07 1950 0001 2006 7335 6328 0002

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Nov 26, 2025	Aid for microenterprises in the form of public interventions concerning electricity, gas or heat supplies	$3$3	E.ON Polska S.A.
Jun 22, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$467$467	Prezes Zakładu Ubezpieczeń Społecznych
Jun 19, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Prezydent Miasta Stołecznego Warszawy

Competitors

Name	Revenue	Website
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
Black & Whitesp. z o.o.	$154,866.36	polonus.pl
Osteoprofsp. z o.o.	$72,065.80	osteoprof.pl
THC PharmaS.A.	$39,093.70	thc-pharma.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Arcade Internationalsp. z o.o.	$17,817.26	arcade-int.pl
Filicosp. z o.o.	$11,710.75	filico.eu
Get Ready Wheelchairssp. z o.o.	$9,842.54	getreadywheelchairs.com
Jacek Waksmundzki Trust 2S.K.A.	$5,769.53	trust.pl
Optimedussp. z o.o.	$1.00	optimedus.pl